Introduction
Impaired glucose tolerance (IGT) is an intermediate state in the transition from normal glucose tolerance (NGT) to type 2 diabetes. IGT subjects are at high risk for progression to type 2 diabetes, with an annual conversion rate of 5-10%, depending upon the ethnic group ( 1 -5 ) . In 1997, the American Diabetes Association (ADA) introduced another intermediate state, impaired fasting glucose (IFG) ( 6 ) , in the transition from NGT to type 2 diabetes. IFG was meant to be analogous to IGT, since subjects with isolated IFG and isolated IGT had similar risk for progression to type 2 diabetes ( 1 -5 ). However, only 45% of subjects with IFG had IGT; conversely, < 25% of subjects with IGT had IFG ( 2 , 3 , 7 -11 ) . The partial overlap between IFG and IGT suggests that different pathophysiological mechanisms contribute to the disturbances in glucose homeostasis. However, the differences in pathophysiological mechanisms between IGT and IFG had not been fully defined. Some studies reported that the primary abnormality in IFG was insulin resistance, while IGT was more associated with impaired β -cell function ( 12 -19 ) . Other studies have reported opposite results ( 20 -24 ) . In 2003, the ADA introduced new diagnostic criteria for IFG based on the receiver operator curve analysis of several prospective epidemiological studies ( 25 ) . As a result of this analysis, the criteria of the fasting plasma glucose (FPG) concentration for IFG was reduced from 110 to 100 mg/dL, and isolated IFG was defined as an FPG of 100-125 mg/dL with 2-h plasma glucose (PG) < 140 mg/dL during the 75 g-oral glucose tolerance test (OGTT) ( 25 ) . Using these new criteria, Abdul-Ghani et al . demonstrated that Mexican American and Caucasian subjects with IGT and IGT/IFG had significantly greater reductions in peripheral (muscle) insulin sensitivity and insulin secretion compared to subjects with IFG ( 26 ) . However, the subject population was obese (body mass index [BMI] > 30 kg/m 2 ) and 3/4 of the subjects were of Hispanic descent ( 26 ) . Little information is available about differences in insulin action and insulin secretion in other ethnic groups with IFG, IGT, and IFG/IGT and in subjects whose BMI is in the normal weight range. Therefore, one aim of the present study was to examine insulin sensitivity and secretion in healthy, normal-weight Japanese subjects who were not taking any medications known to affect glucose tolerance, blood pressure, or lipids levels.
It has also been reported that IGT is associated with an increased prevalence of cardiovascular risk factors ( 27 -30 ) and cardiovascular events ( 30 , 31 ) , whereas IFG is less strongly associated with cardiovascular events and mortality ( 30 , 31 ) . Therefore, a second aim of this study was to examine the association between cardiovascular risk factors (blood pressure and plasma lipids) and IFG, IGT, and IFG/IGT using the 2003 revised ADA criteria in Japanese subjects.
Methods
We have been carrying out a medical examination and epidemiological investigation of cardiovascular disease in the towns of Tanno and Sobetsu, Hokkaido, Japan since 1976 ( 32 ) . From 2,027 citizens who had undergone medical examination and received measurements of anthropometry, blood pressure, plasma lipids, and PG/plasma insulin (PI) concen- trations during 75 g-OGTT in the town of Tanno and Sobetsu, we selected every healthy subject (n= 1,399) who was not taking any medications known to affect glucose tolerance, blood pressure, and plasma lipids levels, and who did not have a history of diabetes. All study subjects were in good general health without evidence of cardiac, hepatic, renal or other chronic diseases as determined by medical history, complete blood cell count (CBC), routine chemistries and ECG. At 8 AM, after a 10-h overnight fast, height and weight were measured and BMI was calculated. Systolic blood pressure (SBP) and diastolic blood pressure (DBP) were measured after 5 min in the reclining position with an automated blood pressure recorder (OMRON HEM 907; OMRON HEALTHCARE, Kyoto, Japan). Blood samples for measurement of fasting plasma lipids (total cholesterol, triglyceride [TG] , high-density lipoprotein [HDL] cholesterol) were obtained through an indwelling catheter. Subjects then ingested 75 g of glucose and blood for measurement of PG and PI concentrations were obtained at 0, 60, and 120 min. Plasma total cholesterol, TG, and HDL cholesterol concentrations were measured enzymatically on an AU5200 autoanalyzer (OLYMPUS, Tokyo, Japan). Low-density lipoprotein (LDL) cholesterol was calculated from the Friedewald equation. PG was measured using the glucose oxidase method, and PI was measured using RIA beads (Dinabot, Tokyo, Japan). Insulin sensitivity indices were calculated from OGTT using the HOMA-R (26, 33) and Matsuda index [10,000/ {(FPG × FPI) × (mean PG × mean PI)} 1/2 ] (26, 34). To evaluate β-cell function, the insulinogenic index was calculated as the incremental area under the curve (AUC) of PI (ΔAUCPI) divided by the incremental AUC of PG (ΔAUCPG) during a 0-120 min (total) time period of the OGTT (26, 35) . The insulin secretion/insulin resistance (disposition) index (ΔAUCPI/ ΔAUCPG × Matsuda index) also was determined to provide a measure of β-cell function (19, 26) . Incremental AUCs of plasma insulin and glucose were calculated according to the trapezoid rule.
Statistical analysis was performed with StatView for Windows, v 5.0 (SAS Institute Inc., Cary, USA). Comparisons between groups were performed using analysis of variance with Scheffe post-hoc testing when appropriate. The χ 2 test was used for comparing proportions between groups.
Stepwise multiple regression analysis was performed to examine the multiple correlations among variables. All data are presented as the mean value±SEM. Values of p< 0.05 were considered statistically significant.
Results
The clinical characteristics and metabolic parameters of each group are summarized in Table 1 . The IFG/IGT group had a higher percentage of males compared with the other three groups. The four groups were similar in age, BMI, and fasting plasma levels of total-, HDL-and LDL-cholesterol. By definition subjects with isolated IFG and combined IFG/IGT had a significantly increased FPG compared to the normal fasting glucose (NFG)/NGT and isolated IGT groups. PG excursions during the OGTT rose progressively from NFG/NGT to IFG to IGT to IFG/IGT, and PG in each group was significantly higher than in the preceding group ( Fig. 1 and Table 1 ). PI excursions during the OGTT were similar in IFG/IGT and IFG and both were significantly greater than in NFG/NGT. PI at 60 min (PI60) during the OGTT was significantly higher in IFG and IGT than in NFG/NGT, while PI at 120 min (PI120) and mean PI during the OGTT were significantly higher in IFG, IGT, and IFG/IGT than in NFG/NGT. The PI120 was significantly higher in IGT than in IFG and IFG/IGT. Blood pressure was significantly higher in IGT compared with NFG/ NGT or IFG. Also, only SBP was significantly higher in IFG than in NFG/NGT. The prevalence of hypertension (SBP≥ 140 mmHg or DBP≥ 90 mmHg) in each group was 20% (235/1,173) in NFG/NGT, 29% (37/128) in IFG, 47% (26/55) in IGT, and 37% (16/43) in IFG/IGT, respectively. The TG concentration and TG/HDL cholesterol ratio were significantly higher in the IGT or IGT/IFG group than in the NFG/NGT group. Furthermore, the IGT/IFG group had a higher TG/HDL cholesterol ratio compared with the IFG group. The differences in metabolic parameters and blood pressure remained even after significant adjustment for gender, age, and BMI. HOMA-R, an index of hepatic insulin resistance, was significantly higher in IFG (2.3±0.1) and IFG/IGT (2.5±0.2) than in NFG/NGT (1.8±0.04) (Fig. 2) . The Matsuda index, a measure of whole body (especially muscle) insulin sensitivity, was significantly reduced in the IFG (6.5±0.3), IGT (5.4±0.4) and IFG/IGT (5.1±0.5) groups compared with the NFG/NGT group (9.5±0.2). ΔAUCPI/ΔAUCPG, an index of β-cell function, was significantly lower in IGT (0.6±0.05) and IFG/IGT (0.5±0.04) compared with IFG (1.4±0.1) or NFG/ NGT (1.2±0.03). The insulin secretion/insulin resistance index of β-cell function (ΔAUCPI/ΔAUCPG × Matsuda index) was significantly lower in the IFG (7.1±0.5) compared to the NGT group and was further and significantly reduced in the IGT (2.7±0.2) and IFG/IGT (2.1±0.2) groups compared with both the NFG/NGT (9.7±0.2) and IFG (7.1±0.5) groups.
Fig. 1. Plasma glucose (PG) and insulin (PI) concentrations during the 75 g-OGTT in subjects with normal fasting glucose and glucose tolerance (NFG/NGT), isolated impaired fasting glucose (IFG), isolated impaired glucose tolerance (IGT), and IFG plus IGT (IFG/IGT).
The predictors of mean blood pressure, TG, and TG/HDL cholesterol ratio were examined in backward stepwise regression analysis using age, gender (male), BMI, FPG, PG60, PG120, FPI, PI60, and PI120 during the OGTT as independent variables (Table 2) . Increased age, BMI, PG120 and PI120, and When performing the same analysis for SBP or DBP, increased age, BMI, PG120 and PI120 were positive predictors of the increase in SBP (adjusted r 2 = 0.12, p< 0.0001), and increased BMI, PG120 and PI60, PI120 and male gender were positive predictors of the increase in DBP (adjusted r 2 = 0.10, p< 0.0001). Increased BMI, PG120, PI60, and male gender were independent positive predictors of the increase in plasma TG (adjusted r 2 = 0.11, p< 0.0001). BMI, PI60 and PI120, decreased FPI, and male gender were independent positive predictors of the increase in TG/HDL cholesterol ratio (adjusted r 2 = 0.15, p< 0.0001) ( Table 2) . Inversely, BMI, PI60 and PI120, decreased FPI, and male gender were independent positive predictors of the decrease in HDL cholesterol (adjusted r 2 = 0.13, p< 0.0001).
Fig. 2. HOMA-R, Matsuda index [10,000/{(FPG × FPI) × (mean PG × mean PI)} 1/2 ], ratio of incremental area under the curve (AUC) of PI to incremental AUC of PG [ΔAUCPI/ΔAUCPG], and Matsuda index × ΔAUCPI/ΔAUCPG during OGTT in subjects with normal fasting glucose and glucose tolerance (NFG/NGT), isolated impaired fasting glucose (IFG), isolated impaired glucose tolerance (IGT), and IFG plus IGT (IFG/IGT). p values indicate significant differences among the groups.

Discussion
In the present study, we investigated the pathophysiological disturbances in Japanese subjects with IFG, IGT, and IFG/ IGT. HOMA-R was significantly higher in subjects with IFG with or without accompanying IGT compared to those with NFG/NGT. The HOMA-R index represents the product of the FPG and FPI concentrations (33) . Since hepatic glucose production (HGP) is the primary determinant of the FPG concentration (36) , and the fasting plasma insulin concentration is the primary regulator of HGP (37), HOMA-R primarily reflects hepatic insulin resistance. Thus, our results indicate that Japanese individuals with IFG are characterized by hepatic insulin resistance. The Matsuda index [10,000/{(FPG × FPI) × (mean PG × mean PI)} 1/2 ] was decreased in the IFG, IGT, and IFG/IGT groups compared to the NFG/NGT group, with a greater reduction in IGT (p= 0.03) with or without IFG (p= 0.05). The Matsuda index is strongly correlated with insulin-stimulated total body glucose disposal, which primarily reflects muscle insulin sensitivity, during the euglycemic insulin clamp (26, 34) . Thus, IGT can be characterized as a state of muscle insulin resistance. β-Cell function, expressed as ΔAUCPI/ΔAUCPG and ΔAUCPI/ΔAUCPG × Matsuda index was more severely reduced in IGT with or without IFG compared with both NFG/NGT and IFG. Thus, Japanese subjects with IGT are characterized by both muscle insulin resistance and impaired insulin secretion. In contrast, IFG represents a state of hepatic insulin resistance with impaired early (0-60 min) but normal to slightly increased late phase (60-120 min) insulin secretion. These distinct metabolic disturbances in hepatic/muscle insulin sensitivity and β-cell function in nondiabetic healthy Japanese subjects with IFG, IGT, and IFG/ IGT are similar to those reported in Mexican-American subjects (26) . However, the severity of hepatic and muscle insulin resistance and the compensatory plasma insulin response following glucose ingestion is much higher in MexicanAmericans (see figure 1 and table 1 in Abdul-Ghani et al. (26) ). The difference in severity in the insulin resistance and hyperinsulinemia most likely reflects the greater obesity and/ or differences in genetic background in the Mexican-American vs. Japanese individuals. We also compared the prevalence of cardiovascular risk factors in healthy Japanese subjects with IFG, IGT, and IFG/ IGT. Of note, no subject was taking any medications known to affect glucose metabolism, blood pressure, or plasma lipid levels. Blood pressure was significantly higher in IGT than in either NFG/NGT or IFG. TG and the TG/HDL cholesterol ratio were significantly higher in IGT and IFG/IGT than in either NFG/NGT or isolated IFG. These findings in Japanese subjects are consistent with previous publications demonstrating an increased prevalence of cardiovascular risk factors and cardiovascular events in subjects with IGT, whereas IFG (defined by the 1997 ADA criteria) appears to be much less strongly associated with cardiovascular disease (27) (28) (29) (30) (31) . The results in the present study, in which IFG and IGT were employed in healthy Japanese subjects, are consistent with the results of these previous reports. However, several studies have reported (using the 1997 ADA criteria) that both IFG and IGT were associated with an increased prevalence of cardiovascular risk factors (38) (39) (40) . Using the 2003 ADA criteria for IFG, Kim et al. (41) did not observe an increased prevalence of cardiovascular risk factors. Because of these conflicting results, we performed multiple regression analysis to define which variables best predicted the presence of cardiovascular risk factors in our population of healthy Japanese subjects. Among the independent variables (age, gender, BMI, FPG, PG60, PG120, FPI, PI60, and PGI120), multiple stepwise regression analysis revealed that male gender, increased age, higher BMI, and elevated PG120 and PI120 were independently and positively associated with increased blood pressure. Many of the same variables (male gender, BMI, higher level of PG60 and PI120) were independently and positively associated with elevated plasma TG levels and an increased TG/ HDL cholesterol ratio. In summary, male gender, obesity, elevated postprandial but not fasting levels of PG and insulin concentrations are associated with cardiovascular risk factors (higher blood pressure and TG, increased TG/HDL cholesterol ratio) in pre-diabetic individuals.
In conclusion, subjects with IFG predominantly manifest hepatic insulin resistance leading to higher FPG and normal/ near-normal indices of β-cell function, while subjects with IGT predominantly manifest peripheral (muscle) insulin resistance combined with impaired β-cell function leading to higher elevations in PG concentration during the postprandial state. Elevated blood pressure, plasma TG, and TG/HDL cholesterol ratio, components of the metabolic or insulin syndrome, are more commonly observed in Japanese subjects with IGT than in those with IFG.
